BlessingBox (@blessingbox4u) 's Twitter Profile
BlessingBox

@blessingbox4u

Technical writer w/ specialization in social media, RN/CRRN, cultural creative, fact hacker, progressive, political junkie, pain advocate, hopeless dog lover!

ID: 1210223678

linkhttp://www.painadvocacycoalition.com calendar_today23-02-2013 00:57:11

24,24K Tweet

1,1K Followers

2,2K Following

Claudia A. Merandi (@cmerandi) 's Twitter Profile Photo

So, they actually tried this, but the study had to be halted Opioid-free anesthesia: Time to regain our balance pmc.ncbi.nlm.nih.gov/articles/PMC79…

PAC (@pacriseup) 's Twitter Profile Photo

“The disciplinary process, often described as a “fishing expedition,” disproportionately harms pain management physicians through aggressive investigations, inadequate due process, unfair penalties, and reliance on outdated rules and unqualified experts.” kevinmd.com/2025/08/why-pa…

Pain News Network (@painnewsnetwork) 's Twitter Profile Photo

The DEA plans to cut the supply of oxycodone again next year -- at a time when there are oxycodone shortages and some drug manufacturers have stopped making oxycodone products. rebrand.ly/dea-plans-736c…

Julie Killingworth Kasel ⭐️🌟 (@jmkillingnyc) 's Twitter Profile Photo

Pain News Network Pain News Network Pat, this is going to happen every year because DEA HQ amended a Statue the CSA in 2018 solely based on the 2016 @CDC guidelines. The Statue 1303.11 had not been touched since 1974. PROP Cohorts Patterson and Dhillon did this sneaky maneuver between

PAC (@pacriseup) 's Twitter Profile Photo

“Unlike previous years, when there was a 30-day period for public comments on DEA’s quota proposal, the agency is only allowing about 2 weeks. You can leave a comment here ⤵️, but it must be posted no later 12/15/25.” painnewsnetwork.org/stories/2025/1…

PAC (@pacriseup) 's Twitter Profile Photo

ITS A 💩 MOVE. ⬇️ public comment ⬇️ production Preemptive move by DEA before FDA can respond to the recent Reagan-Udall Foundation report regarding the need to o change DEA quota policy. See report. reaganudall.org/publications/d… DPF Interpretation patreon.com/posts/143949102

Chad D. Kollas, MD (he/him/his) (@chaddkollas) 's Twitter Profile Photo

At this point, DEA HQ opioid production quotas have become a self-fulfilling prophecy. Reduced production forces shortages and reduced dispensed medications, which DEA cites as evidence to justify further production reductions. Has this reduced opioid-involved overdose deaths?

BlessingBox (@blessingbox4u) 's Twitter Profile Photo

“A core danger arises because proprietary design/secrecy prevent scrutiny of core methodology, creating an “illusion of scientific certainty” where complex graphics simulate knowledge-not traditional evidence.” If you are not watching “Explainer” vignettes, you are not informed.

Dee (@deeenst) 's Twitter Profile Photo

This is so upsetting! What has happened to health care? A young woman's pain ignored? What happened to testing? Nothando Nhlizito

PAC (@pacriseup) 's Twitter Profile Photo

CMS ACCESS Model, ie; Advancing Chronic Care w/ Effective, Scalable Solutions. CMS w/ test outcome aligned payment approach designed to give people w/ Original Medicare new options to improve their health prevent/ manage chronic disease w/ technology- youtu.be/tQE-97XztvM

PAC (@pacriseup) 's Twitter Profile Photo

CMS “launching key public infrastructure National Provider Directory, enabling modern identity on Medicare.gov, expanding data-sharing capabilities. But broader transformation depends on private sector stepping up…” Health Technology Ecosystem cms.gov/priorities/hea…

Bev Schechtman🇮🇱 (@ibdgirl76) 's Twitter Profile Photo

The FDA added “opioid-induced hyperalgesia” to every opioid label in 2023, before their own advisors admitted there’s: • No definition • No diagnostic method • No evidence in chronic pain • And most clinicians never see it They printed the warning anyway. Has OIH been used

David Smith (@davidesmitty) 's Twitter Profile Photo

Jen Yes, Indivior has suspicious financial ties to the group of doctors who amended the DSM in 2013, with new criteria for OUD, since they have been trying their hardest to get all chronic opioid patients diagnosed with OUD as a way to increase sales of buprenorphine and Suboxone

<a href="/jenslife17/">Jen</a> Yes, Indivior has suspicious financial ties to the group of doctors who amended the DSM in 2013, with new criteria for OUD, since they have been trying their hardest to get all chronic opioid patients diagnosed with OUD as a way to increase sales of buprenorphine and Suboxone
PAC (@pacriseup) 's Twitter Profile Photo

Dee Treating pain includes a “definitive diagnosis rendered within a reasonable time frame” to prevent complications, disability and mortality. Delayed diagnosis & plan of care is negligence & malpractice. This is why we advocate. thesun.co.uk/health/3735481… people.com/22-year-old-di…